2007
DOI: 10.1016/j.hrthm.2006.12.047
|View full text |Cite
|
Sign up to set email alerts
|

Application of blebbistatin as an excitation–contraction uncoupler for electrophysiologic study of rat and rabbit hearts

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
333
1
1

Year Published

2008
2008
2024
2024

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 312 publications
(343 citation statements)
references
References 19 publications
8
333
1
1
Order By: Relevance
“…In the present study, we utilized BDM, which is known to change several membrane conductances (6,56) and thereby causes some electrophysiological effects (14,37,40), including flattening the APD restitution curve (3). To examine the potential effect of BDM on the dynamics of cardiac response, we conducted two additional experiments using a new excitation-contraction uncoupling agent, blebbistatin, which is considered to have no effects on the AP morphology in rabbit cardiac tissue (22). Similar to our experiments using BDM, we observed three concurrent dynamics, normal, 2:2, and 2:1 rhythm, when [K ϩ ] o was regionally elevated and PI was shortened to 140 ms.…”
Section: Discussionmentioning
confidence: 64%
“…In the present study, we utilized BDM, which is known to change several membrane conductances (6,56) and thereby causes some electrophysiological effects (14,37,40), including flattening the APD restitution curve (3). To examine the potential effect of BDM on the dynamics of cardiac response, we conducted two additional experiments using a new excitation-contraction uncoupling agent, blebbistatin, which is considered to have no effects on the AP morphology in rabbit cardiac tissue (22). Similar to our experiments using BDM, we observed three concurrent dynamics, normal, 2:2, and 2:1 rhythm, when [K ϩ ] o was regionally elevated and PI was shortened to 140 ms.…”
Section: Discussionmentioning
confidence: 64%
“…The use of two excitation wavelengths for Fura-2/AM-based Ca 2+ measurements further compounds this. Also, uncoupling contraction from excitation and Ca 2+ release is necessary for the current protocols; achieved by BDM and blebbistatin, but this may confound the morphology of APs and CaTs, especially in the whole-heart preparation [29], although minimal effects of BDM [30] and blebbistatin [31] have also been reported. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 …”
Section: Strengthsmentioning
confidence: 99%
“…Furthermore, selective treatment with blebbistatin has been demonstrated as a tool to synchronize mammalian culture cells during different stages of mitotic division (metaphase, anaphase, telophase), a task that proved difficult in the past due to the short duration of anaphase [72]. In addition, both BDM and blebbistatin have been used to eliminate the 'motion artifacts' caused by muscle contractions during live optical imaging of cardiac electrical activity [73,74]. On a more practical therapeutic level, treatment with BDM has been highlighted as a means of increasing the storage lifetime and efficiency of heart transplantation, as BDM treatment reduces stress and metabolic deregulation in donor hearts [46,83].…”
mentioning
confidence: 99%